Jane Street employees set to get $2.68 million payout after record revenue haulJane Street Group surged to the top of Wall Street with record trading revenue and $9.38 billion in compensation. Its unconventional struct...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
Delhi High Court caps imported antibody kit price at Rs. 400COVID-19 test kits should be made available urgently at the lowest possible price so that the virus can be controlled and people's health c...
A new approval route, no WTO rules breach: India on Chinese investment blockChina has itself put restrictions for entry of firms including from India such as IT and pharma.
- Matrix Laboratories founder Nimmagadda Prasad doctored government pact for port, industrial projects: CBI
CBI has accused Nimmagadda Prasad of conspiring with public servants to alter the agreement entered into with the government for his port a...
- Mylan Laboratories looks for partners to launch drugs
Matrix Laboratories, which was acquired by Mylan , is exploring new partnerships in India to launch about 100 products.
- Court asks Matrix not to sell generic of Roche’s cancer drug
The Madras High Court (HC) has asked Hyderabad-based Matrix Laboratories not to make or sell the generic version of Swiss major Roche’s can...
- Matrix Labs pulled up for quality breach
The incidence of failure to meet the quality norms in the pharmaceutical sector has been on the rise. Now, Hyderabad-based Matrix Laborator...
- Matrix drags Israeli co Teva to court over patent issue
The dust hasn’t settled yet on the Novartis case and another patent dispute has emerged in the pharma space.
- Matrix parent co to invest in Astrix Lab
Matrix Laboratories has assigned its parent company, MP Laboratories, purchase rights to a part of the equity of Astrix Laboratories. Matri...
- Matrix weighs Docpharma sale
Hyderabad-based Matrix Labs, in which US-based Mylan Labs holds a controlling stake, is toning up its business focus.
- Matrix Labs mulls Docpharma stake sale
Matrix Laboratories is exploring strategic alternatives including a possible of selling Docpharma business.
- Masterminded Matrix Lab’s rise to the top
The first-generation entrepreneur who masterminded Matrix Lab’s rise to the top is now focusing his efforts on promoting entrepreneurship.
- Mylan Labs may use Indian platform for global pharma play
With the acquisition of Merck KGaA’s generic business by Mylan Laboratories, India is set to become a major manufacturing hub for the US dr...
- 'Deal is first step towards globalisation'
Matrix Labs’ CEO Rajiv Malik, who came on board July last year, appears to have his task cut out.
- US pharma major Mylan buys Matrix Labs
The generic drugs major will acquir Hyderabad-based Matix Lab in a cash-and-stock deal worth Rs 3,424 cr.
- Mylan to buy into Matrix
Mylan Laboratories’ India foray may be just round the corner - the US company is set to pick up a major stake in Secunderabad-based Matrix ...